Information for "Rate of recurrence associated with S492R variations in the epidermis growth factor receptor evaluation regarding lcd Genetics via people together with metastatic intestines cancers treated with panitumumab or even cetuximab monotherapy"
From EECH Central
Basic information
| Display title | Rate of recurrence associated with S492R variations in the epidermis growth factor receptor evaluation regarding lcd Genetics via people together with metastatic intestines cancers treated with panitumumab or even cetuximab monotherapy |
| Default sort key | Rate of recurrence associated with S492R variations in the epidermis growth factor receptor evaluation regarding lcd Genetics via people together with metastatic intestines cancers treated with panitumumab or even cetuximab monotherapy |
| Page length (in bytes) | 3,445 |
| Page ID | 1391299 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Spoonharbor17 (Talk | contribs) |
| Date of page creation | 07:12, 22 April 2024 |
| Latest editor | Spoonharbor17 (Talk | contribs) |
| Date of latest edit | 07:12, 22 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
